Piper Sandler Maintains Neutral on Dentsply Sirona, Lowers Price Target to $12

Benzinga Newsdesk www.benzinga.com Negative 54.1%

Neg 54.1% Neu 0% Pos 0%

Piper Sandler analyst Jason Bednar maintains Dentsply Sirona (NASDAQ:XRAY) with a Neutral and lowers the price target from $14 to $12.